PL359495A1 - Sposób wytwarzania soli peptydów, ich zastosowanie oraz preparaty farmaceutyczne zawierające te sole - Google Patents

Sposób wytwarzania soli peptydów, ich zastosowanie oraz preparaty farmaceutyczne zawierające te sole

Info

Publication number
PL359495A1
PL359495A1 PL01359495A PL35949501A PL359495A1 PL 359495 A1 PL359495 A1 PL 359495A1 PL 01359495 A PL01359495 A PL 01359495A PL 35949501 A PL35949501 A PL 35949501A PL 359495 A1 PL359495 A1 PL 359495A1
Authority
PL
Poland
Prior art keywords
peptide
peptide salts
producing
pharmaceutical preparations
preparations containing
Prior art date
Application number
PL01359495A
Other languages
English (en)
Other versions
PL204496B1 (pl
Inventor
Michael Damm
Waldemar Salonek
Jurgen Engel
Horst Bauer
Gabriele Stach
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27805895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL359495(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL359495A1 publication Critical patent/PL359495A1/pl
Publication of PL204496B1 publication Critical patent/PL204496B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL359495A 2000-08-17 2001-08-09 Sposób wytwarzania zasadowych antagonistów peptydowych LHRH PL204496B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040700A DE10040700A1 (de) 2000-08-17 2000-08-17 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
CA002355573A CA2355573A1 (en) 2000-08-17 2001-08-22 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts

Publications (2)

Publication Number Publication Date
PL359495A1 true PL359495A1 (pl) 2004-08-23
PL204496B1 PL204496B1 (pl) 2010-01-29

Family

ID=27805895

Family Applications (1)

Application Number Title Priority Date Filing Date
PL359495A PL204496B1 (pl) 2000-08-17 2001-08-09 Sposób wytwarzania zasadowych antagonistów peptydowych LHRH

Country Status (29)

Country Link
US (1) US6780972B2 (pl)
EP (1) EP1309607B1 (pl)
JP (1) JP2004506647A (pl)
CN (1) CN1187369C (pl)
AR (1) AR030371A1 (pl)
AT (1) ATE280779T1 (pl)
AU (2) AU2002210439B2 (pl)
BG (1) BG107612A (pl)
BR (1) BR0113296A (pl)
CA (1) CA2355573A1 (pl)
CZ (1) CZ2003688A3 (pl)
DE (2) DE10040700A1 (pl)
DK (1) DK1309607T3 (pl)
EE (1) EE200300065A (pl)
ES (1) ES2230371T3 (pl)
HU (1) HUP0300738A3 (pl)
IL (1) IL154150A0 (pl)
MX (1) MXPA03001448A (pl)
NO (1) NO20030618L (pl)
NZ (1) NZ524023A (pl)
PL (1) PL204496B1 (pl)
PT (1) PT1309607E (pl)
RU (1) RU2266296C2 (pl)
SI (1) SI1309607T1 (pl)
SK (1) SK3032003A3 (pl)
TW (1) TWI236910B (pl)
UA (1) UA74005C2 (pl)
WO (1) WO2002014347A2 (pl)
ZA (1) ZA200300777B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US7098305B2 (en) * 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) * 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
RU2525661C2 (ru) * 2012-11-15 2014-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" Российской академии медицинских наук (ФГБУ "НИИВС им. И.И. Мечникова" РАМН) Способ получения высокотитражной антимикробной сыворотки для оценки антигенной активности противостафилококковых вакцин
CN107056894B (zh) * 2017-05-26 2021-07-20 济南康和医药科技有限公司 一种片段法固相合成醋酸加尼瑞克的方法
EP3590526A1 (en) * 2018-07-05 2020-01-08 Antev Limited A lyophilization process and a teverelix-tfa lyophilizate obtained thereby
CN114249800B (zh) * 2020-09-22 2024-07-26 深圳市星银医药有限公司 一种双羟萘酸多肽药物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431635A (en) * 1979-06-13 1984-02-14 Coy David Howard LH-RH Antagonists
ATE8988T1 (de) * 1980-06-02 1984-09-15 Andrew Victor Schally Lh-rh antagonisten.
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
EP0626170A3 (en) * 1993-05-10 1996-03-27 Sandoz Ltd Stabilization of pharmacologically active compounds in delayed release agents.
DE4342092B4 (de) * 1993-12-09 2007-01-11 Zentaris Gmbh Langwirkende Injektionssuspension und Verfahren zur Herstellung
CA2178592C (en) * 1993-12-09 2009-07-28 Zentaris Gmbh Long-acting injection suspensions and a process for their preparation
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TR200002059T2 (tr) * 1998-01-16 2001-01-22 Takeda Chemical Industries, Ltd. Devamlı salınan bileşim, üretim yöntemi ve kullanımı.

Also Published As

Publication number Publication date
DE10040700A1 (de) 2002-02-28
AU1043902A (en) 2002-02-25
RU2266296C2 (ru) 2005-12-20
HUP0300738A3 (en) 2004-08-30
ATE280779T1 (de) 2004-11-15
CN1447817A (zh) 2003-10-08
US6780972B2 (en) 2004-08-24
RU2003107560A (ru) 2005-01-27
CA2355573A1 (en) 2003-02-22
MXPA03001448A (es) 2004-12-13
AU2002210439B2 (en) 2005-10-20
TWI236910B (en) 2005-08-01
DK1309607T3 (da) 2005-01-17
IL154150A0 (en) 2003-07-31
BG107612A (bg) 2003-12-31
PT1309607E (pt) 2005-02-28
DE50104316D1 (de) 2004-12-02
ZA200300777B (en) 2003-09-18
EE200300065A (et) 2004-12-15
CZ2003688A3 (cs) 2004-03-17
UA74005C2 (en) 2005-10-17
EP1309607A2 (de) 2003-05-14
ES2230371T3 (es) 2005-05-01
JP2004506647A (ja) 2004-03-04
WO2002014347A2 (de) 2002-02-21
HUP0300738A2 (hu) 2003-09-29
AR030371A1 (es) 2003-08-20
US20020198146A1 (en) 2002-12-26
WO2002014347A3 (de) 2002-08-08
CN1187369C (zh) 2005-02-02
BR0113296A (pt) 2003-07-15
NO20030618D0 (no) 2003-02-07
SK3032003A3 (en) 2004-05-04
EP1309607B1 (de) 2004-10-27
NZ524023A (en) 2004-11-26
SI1309607T1 (en) 2005-02-28
PL204496B1 (pl) 2010-01-29
NO20030618L (no) 2003-02-07
HK1058366A1 (en) 2004-05-14

Similar Documents

Publication Publication Date Title
CA2372339A1 (en) Pharmaceutical product comprising the active substance diamorphine, and its use in a process for treating opiate addiction
AU2001279710A1 (en) Magnesium-ammonium-phosphate cements, the production of the same and the use thereof
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
IL152776A (en) Compounds of triazolo pyrimidine and process for their preparation
ZA200202525B (en) α-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0301645A3 (en) Hydropyridine derivative acid addition salts, process for their preparation, pharmaceutical compositions containing them and their use
DK1409116T3 (da) Elektrodialyse af flervalente metalsalte
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
PL359495A1 (pl) Sposób wytwarzania soli peptydów, ich zastosowanie oraz preparaty farmaceutyczne zawierające te sole
WO2000048477A3 (en) Acidic solution of sparingly-soluble group iia complexes
CA2235642A1 (en) Processes for preparing sildenafil
ATE295690T1 (de) Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat
PT1280812E (pt) Ciclipostinas, processo para a sua preparacao e sua utilizacao
WO2002092565A3 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
AU2002210439A1 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
WO2001049605A3 (fr) Procede de preparation de borates de terre rare et utilisation des borates obtenus en luminescence
BR9911969A (pt) Sal e processos para a preparação de um sal, para a preparação de acetato de n-terc-butilhidroxilamina, para o isolamento de acetato de n-terc- butilhidroxilamina, e para a purificação do acetato de n-terc- butilhidroxilamina
PL373247A1 (pl) Sposób leczenia nowotworów drogą podawania tegafuru, uracylu, kwasu folinowego i cyklofosfoamidu
GB0008179D0 (en) Chemical process
AU2002221914A1 (en) Method for producing n-substituted hydroxylamines and the salts thereof
BR0116231A (pt) Método de formação de uma mistura do produto de reação
MXPA04000953A (es) Derivados sustituidos del acido 5,6,6a,11b-tetrahidro-7-oxa-aza-benzo[c]fluoren-6-carboxilico como antagonista de nmda.
UA67941C2 (en) A method for ammonium regeneration from the filtering liquid of ammonium-soda production
BR0102760A (pt) Catalisador para uso na produção de dialcanolamina pela reação de amÈnia com óxido de alquileno e método para a produção do mesmo

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20100809